FDA Device Intelligence
HomeWallac Oy › NeoBase Non-derivatized Assay Solutions

NeoBase Non-derivatized Assay Solutions

Wallac Oy · Model 3041-0020 · UDI-DI 06438147295692

NQL
2
510(k) clearances
3
Adverse events
3
Recalls
1
Facilities

Description

This reagent package is intended for sample processing in the assay of in vitro measurement and evaluation of the concentrations of amino acids, succinylacetone and acylcarnitines in dried blood spot samples (DBS) on filter paper. This reagent package is used together with the NeoBase Non-derivatized MSMS Kit and the NeoBase Succinylacetone Assay Solution.

Recalls

DateFirmReason
2017-11-02PerkinElmer Life and Analytical Sciences, Wallac, OYThere is a potential for leaking vials for certain lot numbers where, if proper attire is not used as instructed, a transient minor allergic skin reaction may result when handling
2012-11-26PerkinelmerTruncated V-Bottomed Microplate Wells used in assays contain defective wells.
2005-03-11Perkin Elmer Life And AnalyticalPump failure may effect data integrity

Query this across every FDA database — by API.

Linked GUDID · 510(k)/PMA · MAUDE · recalls · establishments. Free tier, no card required.

Get your free API keyRead the docs
Data compiled from public U.S. FDA sources (GUDID, 510(k)/PMA, MAUDE, recalls, establishment registration). Adverse-event reports are unverified and do not establish causation. Informational only — not medical, clinical, or regulatory advice.